Literature DB >> 18791867

Adjusted estimates for time-to-event endpoints.

Barry E Storer1, Ted A Gooley, Michael P Jones.   

Abstract

In the analysis of retrospective data or when interpreting results from a single-arm phase II clinical trial relative to historical data, it is often of interest to show plots summarizing time-to-event outcomes comparing treatment groups. If the groups being compared are imbalanced with respect to factors known to influence outcome, these plots can be misleading and seemingly incompatible with results obtained from a regression model that accounts for these imbalances. We consider ways in which covariate information can be used to obtain adjusted curves for time-to-event outcomes. We first review a common model-based method and then suggest another model-based approach that is not as reliant on model assumptions. Finally, an approach that is partially model free is suggested. Each method is applied to an example from hematopoietic cell transplantation.

Entities:  

Mesh:

Year:  2008        PMID: 18791867      PMCID: PMC2660858          DOI: 10.1007/s10985-008-9098-9

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  5 in total

1.  A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.

Authors:  Xu Zhang; Fausto R Loberiza; John P Klein; Mei-Jie Zhang
Journal:  Comput Methods Programs Biomed       Date:  2007-09-11       Impact factor: 5.428

2.  Covariance analysis of censored survival data.

Authors:  N Breslow
Journal:  Biometrics       Date:  1974-03       Impact factor: 2.571

3.  Corrected group prognostic curves and summary statistics.

Authors:  I M Chang; R Gelman; M Pagano
Journal:  J Chronic Dis       Date:  1982

4.  Adjusted survival curve estimation using covariates.

Authors:  R W Makuch
Journal:  J Chronic Dis       Date:  1982

5.  Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.

Authors:  Mohamed L Sorror; Barry E Storer; David G Maloney; Brenda M Sandmaier; Paul J Martin; Rainer Storb
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

  5 in total
  13 in total

1.  Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.

Authors:  Shailender Bhatia; Barry E Storer; Jayasri G Iyer; Ata Moshiri; Upendra Parvathaneni; David Byrd; Arthur J Sober; Vernon K Sondak; Jeffrey E Gershenwald; Paul Nghiem
Journal:  J Natl Cancer Inst       Date:  2016-05-31       Impact factor: 13.506

2.  Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer.

Authors:  S K Allensworth; C L Langstraat; J R Martin; M A Lemens; M E McGree; A L Weaver; S C Dowdy; K C Podratz; J N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2013-06-05       Impact factor: 5.482

3.  Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.

Authors:  Ryan D Cassaday; Barry E Storer; Mohamed L Sorror; Brenda M Sandmaier; Katherine A Guthrie; David G Maloney; Joseph G Rajendran; John M Pagel; Mary E Flowers; Damian J Green; Andrew R Rezvani; Rainer F Storb; Oliver W Press; Ajay K Gopal
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-01       Impact factor: 5.742

4.  The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.

Authors:  Bart L Scott; Ted A Gooley; Mohamed L Sorror; Andrew R Rezvani; Michael L Linenberger; Jonathan Grim; Brenda M Sandmaier; David Myerson; Thomas R Chauncey; Rainer Storb; Veronika Buxhofer-Ausch; Jerald P Radich; Frederick R Appelbaum; H Joachim Deeg
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

5.  Gluten Intake and Risk of Celiac Disease: Long-Term Follow-up of an At-Risk Birth Cohort.

Authors:  Karl Mårild; Fran Dong; Nicolai A Lund-Blix; Jennifer Seifert; Anna E Barón; Kathleen C Waugh; Iman Taki; Ketil Størdal; German Tapia; Lars C Stene; Randi K Johnson; Edwin Liu; Marian J Rewers; Jill M Norris
Journal:  Am J Gastroenterol       Date:  2019-08       Impact factor: 10.864

6.  Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Authors:  Dwight E Yin; Meredith G Warshaw; William C Miller; Hannah Castro; Susan A Fiscus; Lynda M Harper; Linda J Harrison; Nigel J Klein; Joanna Lewis; Ann J Melvin; Gareth Tudor-Williams; Ross E McKinney
Journal:  Pediatrics       Date:  2014-10       Impact factor: 7.124

7.  Cord-Blood Transplantation in Patients with Minimal Residual Disease.

Authors:  Filippo Milano; Ted Gooley; Brent Wood; Ann Woolfrey; Mary E Flowers; Kristine Doney; Robert Witherspoon; Marco Mielcarek; Joachim H Deeg; Mohamed Sorror; Ann Dahlberg; Brenda M Sandmaier; Rachel Salit; Effie Petersdorf; Frederick R Appelbaum; Colleen Delaney
Journal:  N Engl J Med       Date:  2016-09-08       Impact factor: 91.245

8.  An ensemble survival model for estimating relative residual longevity following stroke: Application to mortality data in the chronic dialysis population.

Authors:  Milind A Phadnis; James B Wetmore; Theresa I Shireman; Edward F Ellerbeck; Jonathan D Mahnken
Journal:  Stat Methods Med Res       Date:  2015-09-24       Impact factor: 3.021

9.  High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.

Authors:  Ryan D Cassaday; Philip A Stevenson; Theodore A Gooley; Thomas R Chauncey; John M Pagel; Joseph Rajendran; Brian G Till; Mary Philip; Johnnie J Orozco; William I Bensinger; Leona A Holmberg; Andrei R Shustov; Damian J Green; Stephen D Smith; Edward N Libby; David G Maloney; Oliver W Press; Ajay K Gopal
Journal:  Br J Haematol       Date:  2015-10-12       Impact factor: 6.998

10.  Factors related to age at natural menopause: longitudinal analyses from SWAN.

Authors:  Ellen B Gold; Sybil L Crawford; Nancy E Avis; Carolyn J Crandall; Karen A Matthews; L Elaine Waetjen; Jennifer S Lee; Rebecca Thurston; Marike Vuga; Siobán D Harlow
Journal:  Am J Epidemiol       Date:  2013-06-20       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.